{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:42:10Z","timestamp":1762004530614},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078588","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T23:04:50Z","timestamp":1384383890000},"page":"e78588","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of \u03b1-Galactosidase A Protein Levels in Serum and Plasma"],"prefix":"10.1371","volume":"8","author":[{"given":"Sachie","family":"Nakano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Makisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayasu","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tsukimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Desnick RJ, Ioannou YA, Eng CM, editors (2001) \u03b1-Galactosidase A deficiency: Fabry disease. Eight ed. New York: McGraw-Hill Inc. 3733\u20133774 p.","DOI":"10.1006\/rwgn.2001.0443"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10038-008-0316-9","article-title":"Structural characterization of mutant alpha-galactosidases causing Fabry disease","volume":"53","author":"K Sugawara","year":"2008","journal-title":"J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00223869","article-title":"Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins","volume":"95","author":"T Okumiya","year":"1995","journal-title":"Hum Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","article-title":"Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns","volume":"55","author":"BH Lee","year":"2010","journal-title":"J Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ymgme.2012.01.010","article-title":"Fabry disease: biochemical, pathological and structural studies of the \u03b1-galactosidase A with E66Q amino acid substitution","volume":"105","author":"T Togawa","year":"2012","journal-title":"Mol Genet Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"M Yasuda","year":"2003","journal-title":"Hum Mutat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"R Schiffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease","volume":"345","author":"CM Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"F Weidemann","year":"2009","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"R Schiffmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","first-page":"823","article-title":"Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease","volume":"2","author":"FC Fervenza","year":"2008","journal-title":"Biologics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2008.10.004","article-title":"A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease","volume":"96","author":"B Benichou","year":"2009","journal-title":"Mol Genet Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2008.03.003","article-title":"Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3","volume":"94","author":"AC Vedder","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10545-011-9400-y","article-title":"Fabry disease, enzyme replacement therapy and the significance of antibody responses","volume":"35","author":"PB Deegan","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1373\/clinchem.2004.037937","article-title":"Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease","volume":"50","author":"M Fuller","year":"2004","journal-title":"Clin Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00467-008-0846-6","article-title":"Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes","volume":"23","author":"T Kitagawa","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0167-4838(94)90017-5","article-title":"Human alpha-galactosidase gene expression: significance of two peptide regions encoded by exons 1\u20132 and 6","volume":"1204","author":"S Ishii","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-291X(03)01364-0","article-title":"A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins","volume":"308","author":"M Adler","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tibtech.2005.02.006","article-title":"Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification","volume":"23","author":"CM Niemeyer","year":"2005","journal-title":"Trends Biotechnol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1439758","article-title":"Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates","volume":"258","author":"T Sano","year":"1992","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1093\/nar\/21.25.6038","article-title":"Universal immuno-PCR for ultra-sensitive target protein detection","volume":"21","author":"H Zhou","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1093\/nar\/18.21.6409","article-title":"Optimization of the annealing temperature for DNA amplification in vitro","volume":"18","author":"W Rychlik","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/jhg.2012.68","article-title":"High-throughput screening identified disease-causing mutants and functional variants of alpha-galactosidase A gene in Japanese male hemodialysis patients","volume":"57","author":"K Doi","year":"2012","journal-title":"J Hum Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Y Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/nar\/23.3.522","article-title":"High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction","volume":"23","author":"ER Hendrickson","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/abio.2000.4578","article-title":"Immunopolymerase chain reaction using real-time polymerase chain reaction for detection","volume":"281","author":"PW Sims","year":"2000","journal-title":"Anal Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1126\/science.8480182","article-title":"Immuno-PCR with a commercially available avidin system","volume":"260","author":"V Ruzicka","year":"1993","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gng090","article-title":"Combination of DNA-directed immobilization and immuno-PCR: very sensitive antigen detection by means of self-assembled DNA-protein conjugates","volume":"31","author":"CM Niemeyer","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.bbrc.2009.12.101","article-title":"NBBA, a synthetic small molecule, inhibits TNF-alpha-induced angiogenesis by suppressing the NF-kappaB signaling pathway","volume":"391","author":"NH Kim","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.109.931931","article-title":"Int6\/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression","volume":"122","author":"L Chen","year":"2010","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2007.06.013","article-title":"Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy","volume":"92","author":"T Ohashi","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2008.03.008","article-title":"Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease","volume":"94","author":"T Ohashi","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta","volume":"66","author":"GE Linthorst","year":"2004","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e47805","DOI":"10.1371\/journal.pone.0047805","article-title":"Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso) Gb3 reduction and treatment outcome","volume":"7","author":"SM Rombach","year":"2012","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:25:55Z","timestamp":1564687555000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078588"}},"subtitle":[],"editor":[{"given":"Richard C.","family":"Willson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078588","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}